• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见原发性血管炎:多种复杂疾病的最新进展和崭露头角的新疾病。

Rare primary vasculitis: update on multiple complex diseases and the new kids on the block.

机构信息

Rheumatology Division, Universidade Federal de São Paulo, Rua Botucatu, 740, 3° andar, São Paulo, SP, 04023-062, Brazil.

出版信息

Adv Rheumatol. 2024 Oct 9;64(1):79. doi: 10.1186/s42358-024-00421-8.

DOI:10.1186/s42358-024-00421-8
PMID:39385260
Abstract

Systemic vasculitis is a group of rare diseases that share an essential characteristic: inflammation of blood vessel walls. This injury occurs during the disease course, but specific features vary for each entity. In this paper, we will address relevant aspects of the newest monogenic mutation vasculitis, such as deficiency of adenosine deaminase 2 (ADA2) and VEXAS syndrome (UBA1), and other relevant vasculitis, such as Cogan syndrome and Susac syndrome that may share some similarities with them.

摘要

系统性血管炎是一组罕见疾病,它们具有一个共同的特征:血管壁炎症。这种损伤发生在疾病过程中,但每种疾病的具体特征都有所不同。在本文中,我们将讨论最新的单基因突变血管炎,如腺苷脱氨酶 2 缺乏症(ADA2)和 VEXAS 综合征(UBA1),以及其他相关血管炎,如 Cogan 综合征和 Susac 综合征,它们可能与这些疾病有一些相似之处。

相似文献

1
Rare primary vasculitis: update on multiple complex diseases and the new kids on the block.罕见原发性血管炎:多种复杂疾病的最新进展和崭露头角的新疾病。
Adv Rheumatol. 2024 Oct 9;64(1):79. doi: 10.1186/s42358-024-00421-8.
2
Cutaneous vasculitis in autoinflammatory diseases.自身炎症性疾病中的皮肤血管炎。
J Dermatol. 2024 Feb;51(2):150-159. doi: 10.1111/1346-8138.17030. Epub 2023 Nov 13.
3
Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.腺苷脱氨酶2缺乏症:临床表现、诊断与治疗
Rheum Dis Clin North Am. 2023 Nov;49(4):773-787. doi: 10.1016/j.rdc.2023.06.004. Epub 2023 Aug 1.
4
Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.腺苷脱氨酶 2 缺乏症(DADA2):表型、遗传学、发病机制和治疗的最新进展。
J Clin Immunol. 2018 Jul;38(5):569-578. doi: 10.1007/s10875-018-0525-8. Epub 2018 Jun 27.
5
[Multiple facets of ADA2 deficiency: Vasculitis, auto-inflammatory disease and immunodeficiency: A literature review of 135 cases from literature].[ADA2缺乏症的多方面表现:血管炎、自身炎症性疾病和免疫缺陷:对文献中135例病例的综述]
Rev Med Interne. 2018 Apr;39(4):297-306. doi: 10.1016/j.revmed.2017.11.006. Epub 2017 Dec 19.
6
Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).腺苷脱氨酶 2 缺乏症(DADA2)的疾病表型的基因型和功能相关性。
J Allergy Clin Immunol. 2020 Jun;145(6):1664-1672.e10. doi: 10.1016/j.jaci.2019.12.908. Epub 2020 Jan 13.
7
Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.在儿科血管炎中鉴定新型腺苷脱氨酶 2 基因突变及不同的临床表型。
Arthritis Rheumatol. 2019 Oct;71(10):1747-1755. doi: 10.1002/art.40913. Epub 2019 Aug 26.
8
A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.一种具有多种表型的单基因疾病:腺苷脱氨酶 2 缺乏症。
J Rheumatol. 2020 Jan;47(1):117-125. doi: 10.3899/jrheum.181384. Epub 2019 May 1.
9
Deficiency of adenosine deaminase 2 (DADA2): Review.腺苷脱氨酶2缺乏症(DADA2):综述
Best Pract Res Clin Rheumatol. 2023 Mar;37(1):101844. doi: 10.1016/j.berh.2023.101844. Epub 2023 Jun 15.
10
Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis.以痉挛性截瘫和系统性血管炎为表现的腺苷脱氨酶2缺乏症。
J Neurol. 2016 Apr;263(4):818-20. doi: 10.1007/s00415-016-8070-y. Epub 2016 Feb 25.

本文引用的文献

1
Clinical characteristics and treatment approaches in patients with Susac syndrome: a scoping review of cases.Susac 综合征患者的临床特征和治疗方法:病例的范围综述。
J Neurol. 2023 Dec;270(12):5719-5730. doi: 10.1007/s00415-023-11936-3. Epub 2023 Sep 5.
2
Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about mosaicism.西班牙语人群 VEXAS 综合征:临床表现、治疗结果及嵌合体新证据。
Ann Rheum Dis. 2023 Dec;82(12):1594-1605. doi: 10.1136/ard-2023-224460. Epub 2023 Sep 4.
3
VEXAS syndrome: Current clinical, diagnostic and treatment approaches.
VEXAS综合征:当前的临床、诊断及治疗方法
Intractable Rare Dis Res. 2023 Aug;12(3):170-179. doi: 10.5582/irdr.2023.01020.
4
VEXAS syndrome: a diagnostic puzzle.VEXAS 综合征:一个诊断难题。
RMD Open. 2023 Aug;9(3). doi: 10.1136/rmdopen-2023-003332.
5
Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort.全国 DADA2 队列的临床症状、实验室参数和长期随访。
J Clin Immunol. 2023 Oct;43(7):1581-1596. doi: 10.1007/s10875-023-01521-8. Epub 2023 Jun 5.
6
How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies.如何治疗 VEXAS 综合征:当前治疗策略的有效性和安全性的系统评价。
Rheumatology (Oxford). 2023 Nov 2;62(11):3518-3525. doi: 10.1093/rheumatology/kead240.
7
Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation.VEXAS 相关自身免疫表现:整合的机会与解读的陷阱。
J Allergy Clin Immunol. 2023 May;151(5):1204-1214. doi: 10.1016/j.jaci.2023.02.017. Epub 2023 Mar 21.
8
Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings.VEXAS 综合征的皮肤受累:临床和组织病理学发现。
Int J Dermatol. 2023 Jul;62(7):938-945. doi: 10.1111/ijd.16635. Epub 2023 Mar 8.
9
VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation.VEXAS 综合征:骨髓抽吸和活检中骨髓细胞和红系前体细胞空泡形成的综述报告
Eur J Haematol. 2023 Jun;110(6):633-638. doi: 10.1111/ejh.13944. Epub 2023 Feb 22.
10
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.在临床人群中与 VEXAS 综合征相关的 UBA1 变异体的估计患病率和临床表现。
JAMA. 2023 Jan 24;329(4):318-324. doi: 10.1001/jama.2022.24836.